Engagement summary
Client Background
Terram Lab Corp is a private life-sciences laboratory and diagnostics company in a growth and capital-raising stage with multiple convertible and preferred instruments in the capital structure.
Engagement Scope
R&M provides comprehensive audit readiness, monthly financial reporting package development, KPI and financial-dashboard build-out, ASC 480 debt instrument analyses, ASC 805 purchase accounting, ASC 842 lease implementation, and ASC 718 stock-compensation analyses.
Services Provided
- Audit readiness and workpaper construction
- Monthly financial reporting package development
- KPI and financial dashboard build-out
- ASC 480 debt instrument analysis
- ASC 805 purchase accounting and ASC 842 lease implementation
- ASC 718 stock-based compensation analysis
Valuation context
Terram Lab engaged Rivers & Moorehead for independent valuation support under the standard(s) listed above. The engagement provides valuation analyses, supporting models, and written deliverables intended to assist the company and its external auditors with financial reporting under U.S. GAAP.
Valuation scope
- ASC 718 equity-based compensation valuation – grant-date fair value of stock options, restricted stock, profit interest units, or performance-based awards using Black-Scholes, lattice, or Monte Carlo models as award terms require; supporting documentation for audit.
- ASC 805 purchase price allocation – identification and fair value measurement of acquired identifiable intangible assets (e.g., customer relationships, trade names, developed technology, non-compete agreements), tangible assets, and assumed liabilities, with residual goodwill calculation and opening balance sheet support.